secwatch.observer — SEC 8-K summary
======================================

Issuer:     Applied Therapeutics, Inc. (—)
CIK:        0001697532
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0001104659-22-120350
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied Therapeutics gets Nasdaq deficiency notice as equity falls below $10M minimum
--------------------------------------------------------------------------------

- Stockholders' equity was $9.6M as of Sep 30, 2022, below Nasdaq's $10M continued listing requirement.
- Company has until Dec 30, 2022 to submit a compliance plan to regain compliance.
- If plan accepted, Nasdaq may grant until May 14, 2023 to evidence compliance.
- No decisions on response have been made; continued listing not assured.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1697532/000110465922120350/0001104659-22-120350-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1697532/000110465922120350/tm2230973d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-120350

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer